Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland. Show more
401 Professional Drive, Gaithersburg, MD, 20879, United States
Market Cap
2.159M
52 Wk Range
$3.16 - $55.90
Previous Close
$3.69
Open
$3.71
Volume
2,186,922
Day Range
$3.48 - $4.07
Enterprise Value
1.301M
Cash
1.09M
Avg Qtr Burn
-2.417M
Insider Ownership
62.95%
Institutional Own.
33.77%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|